Related references
Note: Only part of the references are listed.Predicted 30-Year Protection After Vaccination With an Aluminum-Free Virosomal Hepatitis A Vaccine
Patrick A. Bovier et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Hepatitis A Risk in Travelers
Helena H. Askling et al.
JOURNAL OF TRAVEL MEDICINE (2009)
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
Patrick A. Bovier
EXPERT REVIEW OF VACCINES (2008)
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in the elderly
V D'Acremont et al.
JOURNAL OF TRAVEL MEDICINE (2006)
Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine
BR Beck et al.
CLINICAL INFECTIOUS DISEASES (2003)
Inactivated hepatitis A vaccine booster given ≥24 months after the primary dose
P Landry et al.
VACCINE (2000)
Share Paper
